POTS Syndrome — The Root Cause Integrative Guide (2026)

POTS is not idiopathic. It never was.

The single most damaging sentence in the POTS patient journey is: "We're not sure what causes it."

We are sure. The literature has been increasingly clear for a decade. POTS is not a disease — it is a syndrome, meaning a reproducible pattern of dysfunction. And every reproducible pattern of dysfunction has upstream drivers.

For POTS, there are 6–8 of them. They are well-documented. They are testable. And the reason most patients are told "we don't know" is that no single specialty runs the full workup.

This guide is the workup.

The diagnostic picture

The formal criteria first, so we're grounded:

• Sustained HR increase ≥30 bpm within 10 minutes of standing (≥40 bpm in adolescents)
• Without a significant orthostatic drop in BP (that would be orthostatic hypotension, different diagnosis)
• Accompanied by symptoms of cerebral hypoperfusion and autonomic dysregulation
• Symptoms present for ≥3 months

Confirmed by tilt table test or a well-done active stand test with continuous HR monitoring.

That gets you the label. It tells you nothing about the driver.

The 6-8 root drivers, ranked by prevalence

Based on our clinical patient population and the current literature (Vernino, Blitshteyn, Systrom, and the Bateman Horne Center data), here's the actual driver distribution:

1. Mast Cell Activation Syndrome (MCAS)

Probably the single most under-diagnosed driver. Mast cells release histamine, tryptase, prostaglandins, and 200+ other mediators. Chronic dysregulated release destabilizes the autonomic nervous system, drives vascular changes, and produces the exact POTS symptom cluster.

Workup: serum tryptase (baseline + during flare if possible), chromogranin A, 24-hour urine N-methylhistamine + prostaglandin D2 + leukotriene E4, plasma histamine.

Treatment: stabilize (H1 + H2 blockers, cromolyn, quercetin, luteolin, low-histamine diet), then trigger identification and removal.

2. Mold and mycotoxin exposure

Mycotoxins are directly neurotoxic and mast-cell-activating. Ochratoxin A, trichothecenes, and gliotoxin all produce dysautonomia patterns. Any patient with POTS + brain fog + non-specific inflammatory markers + water-damaged building history should be presumed mold until proven otherwise.

Workup: urinary mycotoxin panel (Great Plains or RealTime), ERMI test on the primary indoor environment, MARCoNS nasal culture if chronic sinus symptoms.

Treatment: the full Klinghardt-style mold protocol — remediate environment, sequenced binders, drainage support, mast cell coverage during die-off.

3. Ehlers-Danlos / hypermobility spectrum

Connective tissue laxity affects vascular compliance. The vessels themselves don't hold tone properly on standing, and the resulting compensatory tachycardia is POTS. The Beighton score screens for this in five minutes; almost nobody in conventional cardiology runs it.

Workup: Beighton score, Brighton criteria, genetic panel if classical or vascular EDS suspected, connective tissue-focused PT eval.

Treatment: targeted strengthening PT (Muldowney or CHOP protocol), collagen/glycine/vitamin C nutritional support, compression, avoiding hyper-extension.

4. Cranio-cervical instability (CCI)

Underdiagnosed. Cervical instability irritates the vagus nerve and brainstem autonomic centers. Frequently comorbid with hypermobility. Suspect in POTS patients with occipital headaches, "brain heaviness," symptom worsening with head position.

Workup: upright cervical MRI (not supine — you'll miss it), Clivo-axial angle and Grabb-Oakes measurement.

Treatment: conservative first (targeted PT, prolotherapy in select cases). Surgical fusion is a last resort but genuinely curative for confirmed severe cases.

5. Chronic viral reactivation

EBV, HHV-6, and post-COVID are all documented POTS triggers. The 2020–2024 long-COVID wave made this driver mainstream, but it existed before.

Workup: EBV panel with EA and EBNA (not just heterophile), HHV-6 IgG/IgM, cytokine panel, spike-antibody persistence if post-COVID.

Treatment: antiviral herbs (monolaurin, L-lysine, elderberry), low-dose naltrexone in appropriate cases, mitochondrial support, methylene blue in select cases.

6. HPA-axis dysregulation / adrenal burnout

Chronic sympathetic overdrive → eventual autonomic collapse → POTS. Very common driver in the high-achiever female population.

Workup: 4-point saliva cortisol curve, DHEA-S, pregnenolone, comprehensive thyroid.

Treatment: adrenal-supportive nutrition, adaptogens matched to phase (not generic ashwagandha for everyone), sleep and circadian reset, nervous-system regulation practice.

7. Heavy metal toxicity

Mercury and lead directly damage the autonomic nervous system. Under-tested in conventional workups.

Workup: hair tissue mineral analysis, urine porphyrins, provoked urine metals in select cases, red blood cell mineral panel.

Treatment: identification and removal of source, drainage optimization first, then sequenced clearance protocol (never chelate a patient with poor drainage — you make POTS worse).

8. Autoimmune

Sjögren's, Hashimoto's, autoimmune autonomic ganglionopathy (α3-AChR antibodies), and small fiber neuropathy of autoimmune origin all produce POTS.

Workup: ANA with reflex, SSA/SSB, TPO/TG antibodies, α3-AChR ganglionic antibody, skin biopsy for small fiber neuropathy if indicated.

Treatment: disease-specific. Often requires co-management with rheumatology or autoimmune neurology.

Why "salt and compression socks" is not the answer

It's not that they're wrong. Salt loading and compression genuinely help symptomatic management. They increase blood volume and vascular return, and every POTS patient should be doing them.

They are palliative, not causative. They mask the syndrome. They don't touch the driver. Which is why patients who rely on them alone are still symptomatic five, ten, fifteen years later.

The full answer is: symptomatic support plus driver identification plus driver-specific treatment. That's the entire game.

The actual workup sequence we run

For complex POTS at Integrative You:

Week 1–2: History deep-dive (mold exposure map, viral history, EDS screen, HPA timeline), Beighton score, active stand test with continuous HR monitor.

Labs, first round: Comprehensive metabolic + CBC + thyroid + ferritin/iron studies + 25-OH-D, tryptase, chromogranin A, ANA/SSA/SSB, TPO/TG, EBV panel, morning cortisol + DHEA-S.

Labs, second round (based on first): Urinary mycotoxins, hair mineral analysis, 24-hour histamine metabolites, cortisol curve, α3-AChR antibody if pattern suggests.

Imaging (if indicated): Upright cervical MRI for CCI suspicion, echocardiogram if not already done.

Environmental: ERMI on primary indoor space if any mold suspicion.

This looks expensive because it's front-loaded. It is dramatically cheaper than five years of specialist bouncing without an answer, which is what most POTS patients spend.

What actually resolves POTS

Identify the dominant driver(s). Treat those.

That's the entire clinical answer.

For MCAS-driven POTS, we've seen full remission with proper stabilization + trigger removal within 6–18 months.

For mold-driven POTS, remission tracks the mold protocol timeline — 12–24 months for full clearance in most cases, with symptom improvement typically within 3–6 months of removing the exposure.

For EDS-driven POTS, targeted PT + connective tissue support produces sustained functional improvement in the majority of cases; full symptom resolution is less common but meaningful reduction is standard.

For viral-driven POTS, the antiviral + mitochondrial + LDN protocol resolves a meaningful percentage of cases within 6–12 months, with the rest getting substantial improvement.

The people who don't get better are almost always the ones running a generic protocol on the wrong driver.

Start with the right driver

If you or someone you love has been told POTS is idiopathic, get the workup that actually finds the driver. That's the whole game.

Get your personalized clinical read

Order a Health Decode → — $47, personalized clinical report that starts mapping your specific POTS pattern to the most likely root driver for your case. For complex, multi-driver cases, Private Concierge runs the full workup in one program.